Almac Group Expands with Opening of £20 million Cold Chain Facility
Continued investment in global expansion and service portfolio
Craigavon, N.I., 28 February 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, today announced the completion of a £20 million investment in its cold chain management capabilities with the opening of a 95,000sq ft custom built cold store facility at its global headquarters in Northern Ireland.
Teleflex to Present at Barclays Global Healthcare Conference
WAYNE, Pa.–(BUSINESS WIRE) –Liam Kelly, President and Chief Executive Officer, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami, Florida, on Tuesday, March 13, 2018 at 1:35 pm (ET).
A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.
Read More
IBX to provide Narcan to subscribers for no charge
Philly.com
Independence Blue Cross will make naloxone, the opioid overdose reversal drug, available to its subscribers for no charge, the insurance giant announced on Tuesday. The medication, known best by the brand-name Narcan, is credited with saving thousands of lives in Southeastern Pennsylvania.
“By removing a financial barrier to accessing naloxone, we can make the drug more readily available and hopefully save more lives,” said Richard Snyder, the chief medical officer for Independence and a member of Mayor Kenney’s task force on opioids. “Our hope is that anyone struggling with opioid addiction can get appropriate treatment, but they have to be alive to take that step.”
Independence will grant subscribers up to six syringes of the reversal drug every 30 days effective Mar. 1. The policy will cover members who are purchasing Narcan for themselves or for a covered subscriber.
Almac Diagnostics Partners with DNAnexus to Power Clinical Trial Assay Development
